Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-046916

President & CEO bought 16,000 shares at $125.26 ($2,004,211)

From the SEC's structured data for this filing

Trades in this filing

INGRAM DOUGLAS S · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-08-15 Purchase : show line 1 in the form +16,000 $125.26 $2,004,211 399,250 D
Open-market purchases · 16,000 sh · avg $125.26 · $2,004,211
Loading xslF345X03/doc4.xml…